灵芝多糖现代药理学研究进展  

Progress in Modern Pharmacology of Ganoderma Lucidum Polysaccharides

作　　者：邹玉莲 甘陈灵 李鹏[2] ZOU Yu-lian;GAN Chen-ling;LI Peng(Institute of Immunotherapy,Fujian Medical University,Fuzhou 350122,China;School of Pharmacy,Fujian Medical University,Fuzhou 350122,China)

机构地区：[1]福建医科大学免疫治疗研究所,福州350122 [2]福建医科大学药学院,福州350122

出　　处：《海峡药学》2018年第8期28-30,共3页Strait Pharmaceutical Journal

基　　金：福建省自然科学基金(2015J01678;2017J01824);福建医科大学苗圃基金(2015MP009)

摘　　要：灵芝入药在我国有着悠久的历史。灵芝所含的化学成分复杂,研究表明灵芝多糖是其主要的活性成分,具有广泛的药理作用。本文主要介绍灵芝多糖类化合物的现代药理学研究进展,为灵芝多糖的开发利用提供前沿情报参考。Ganoderma species have a long history of medicinal usage in China. The chemical composition of ganoderma lucidum is complex,and the research indicates that ganoderma polysacciaride is the main active ingredient and has extensive pharmacological effect. This paper mainly introduces the research progress of modern pharmacology of ganoderma polysaccharides,and provides forward information reference for the development and utilization of ganoderma polysaccharides.

关 键 词：灵芝 多糖 化学成分 药理作用 

分 类 号：R350.10[医药卫生—基础医学]